SPIA
SYRS

Steward Partners Investment Advisory’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Steward Partners Investment Advisory’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8
Closed – – 4281
2025
Q1 		$0 Hold
8
– – ﹤0.01% 4176
2024
Q4 		$2 Hold
8
– – ﹤0.01% 3963
2024
Q3 		$17 Hold
8
– – ﹤0.01% 3718
2024
Q2 		$41 Hold
8
– – ﹤0.01% 3578
2024
Q1 		$43 Hold
8
– – ﹤0.01% 3529
2023
Q4 		$62 Buy
+8
New +$27 ﹤0.01% 3456

Steward Partners Investment Advisory's SYRS Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2025, closing a stake of 8 shares.

Steward Partners Investment Advisory first reported a position in SYRS in Q4 2023 and held it in 6 quarters. The position peaked at $62 in Q4 2023. 0 funds tracked by Wall St. Rank hold SYRS as of Q2 2025.

  • Steward Partners Investment Advisory reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 8 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2025.
  • Steward Partners Investment Advisory first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 6 quarters.
  • Steward Partners Investment Advisory's Syros Pharmaceuticals, Inc. Common Stock position peaked at $62 in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.